26 results on '"Rueter, Jens"'
Search Results
2. Health care utilization and behavior changes after workplace genetic testing at a large US health care system
3. Supervised learning with word embeddings derived from PubMed captures latent knowledge about protein kinases and cancer
4. Epistemic Beliefs: Relationship to Future Expectancies and Quality of Life in Cancer Patients
5. Differences in cancer patients’ and clinicians’ preferences for disclosure of uncertain genomic tumor testing results
6. Molecular profiling of gynecologic cancers for treatment and management of disease – demonstrating clinical significance using the AMP/ASCO/CAP guidelines for interpretation and reporting of somatic variants
7. Umbralisib in combination with ibrutinib in patients with relapsed or refractory chronic lymphocytic leukaemia or mantle cell lymphoma: a multicentre phase 1–1b study
8. Sunitinib in Patients With Breast Cancer With FGFR1 or FGFR2 Amplifications or Mutations: Results From the Targeted Agent and Profiling Utilization Registry Study.
9. Patientsʼ Expectations of Benefits From Large-Panel Genomic Tumor Testing in Rural Community Oncology Practices
10. Abemaciclib in patients (pts) with esophageal cancer (EC) with CDKN2A loss or mutation (mut): Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) study.
11. Feasibility and value of genomic profiling in cancer of unknown primary: real-world evidence from prospective profiling study.
12. Advancing Genomic Cancer Medicine in Rural and Underserved States.
13. The Maine Cancer Genomics Initiative: Implementing a Community Cancer Genomics Program Across an Entire Rural State.
14. Urban-Rural and Socioeconomic Differences in Patient Knowledge and Perceptions of Genomic Tumor Testing.
15. Molecular profiling of CNS tumors for the treatment and management of disease
16. Community oncologists' perceptions and utilization of large-panel genomic tumor testing.
17. The influence of uncertainty and uncertainty tolerance on attitudes and self-efficacy about genomic tumor testing.
18. Maine Cancer Genomics Initiative: A Model for Translational Outreach.
19. Additive and synergistic inhibition of mantle cell lymphoma cell growth by combining olaparib with ibrutinib.
20. 307 Patients expectations of benefits from large-panel genomic tumor testing in rural community oncology practices.
21. A Novel Automated Analysis Of Flow Cytometry Data Identifies Distinct Cell Signatures In The Immune System Of CLL Patients
22. Local endothelial complement activation reverses endothelial quiescence, enabling t-cell homing, and tumor control during t-cell immunotherapy.
23. Socioeconomic and Urban-Rural Disparities in Genome-Matched Treatment Receipt and Survival after Genomic Tumor Testing.
24. Feasibility and value of genomic profiling in cancer of unknown primary: real-world evidence from prospective profiling study.
25. CUP-AI-Dx: A tool for inferring cancer tissue of origin and molecular subtype using RNA gene-expression data and artificial intelligence.
26. Genomic Profiling of Two Histologically Distinct Rare Urothelial Cancers in a Clinical Setting to Identify Potential Therapeutic Options for Treatment and Management of Disease.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.